Selskabets formål er at drive handel og industri
| Year | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2024 | 1.9 mia. | 32.8 mio. | 147.4 mio. | 47.7 mio. | 33 | |
CVR: 29431612
Secondary names: Scandinavian Medical Company ApS, EMRAmed ApS
Compared to 406 companies in Engroshandel med medicinalvarer og sygeplejeartikler
Comparison is based on industry median values
PARANOVA PACK ApS exhibits a strong recovery in financial health, with 2024 revenue reaching 1.85 billion DKK and a profit of 32.78 million DKK, marking a significant increase from 2023's revenue of 1.42 billion DKK and profit of 16.98 million DKK. The company has rebounded from a loss in 2022, showcasing a positive trajectory in profitability and revenue growth over the past two years. Notably, equity has improved to 47.69 million DKK in 2024, up from 14.92 million DKK in 2023, indicating a strengthening balance sheet. However, the fluctuating profit margins and previous negative equity raise concerns about long-term stability. Positioned within the wholesale trade of medicinal products and healthcare items, PARANOVA PACK ApS is a significant player in its industry, benefiting from recent growth trends.
AI-generated summary
Erik Bernhard Pfeiffer left the board
Hans-Joachim Oltersdorf left the board
Dirk Andreas Oltersdorf left the board
Companies in the same industry and area
companydata.dk